The role of 99mTc-tetrofosmin pinhole-SPECT in breast cancer axillary lymph node staging

Cancer Biotherapy and Radiopharmaceuticals

Volumn 15, Issue 1, 2000, Pages 81-91

  Spanu, A ^a   Dettori, G ^a   Chiaramida, P ^a   Cottu, P ^a   Falchi, A ^a   Porcu, A ^a   Solinas, M E ^a   Nuvoli, S ^a   Madeddu, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

99mTc Tetrofosmin; Axillary lymph node metastasis; Breast cancer; Pinhole SPECT

Indexed keywords

TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BREAST TUMOR; INSTRUMENTATION; LYMPH NODE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033621914     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2000.15.81     Document Type: Article

References (46)

1. Walsh R, Kornguth PJ, Soo MS, Bentley R, DeLong DM. Axillary lymph nodes: mammographic, pathologic, and clinical correlation. AJR Am J Roentgenol 1997;168(1):33-38.
2. Tate JJ, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1989;15(2):139-141.
3. Bruneton JN, Caramella E, Hery M, Aubanel D, Manzino JJ, Picard JL. Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 1986;158(2):325-326.
4. Pamilo M, Soiva M, Lavast EM. Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med 1989;8(3):115-120.
5. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398.
6. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-339.
7. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276(22):1818-1822.
8. Roumen RM, Valkenburg JG, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997;23(6):495-502.
9. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-1887.
10. Gulec SA, Moffat FL, Carrol RG, Serafini AN, Sfakianakis GN, Allen L, Boggs J, Escobedo D, Pruett CS, Gupta A, Livingstone AS, Krag DN. Sentinel node localization in early breast cancer. J Nucl Med 1998;39(8): 1388-1393.
11. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998;85(7):991-993.
12. Walh RL, Cody RL, August D. Initial evaluation of FDG PET for the staging in newly-diagnosed breast carcinoma patients. J Nucl Med 1991;32 (5):981.
13. Utech CI, Young CS, Winter PF. Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med 1996;23(12): 1588-1593.
14. Adler LP, Faulhaber PF, Schnur KC, Al-Kasi NL, Shenk RR. Axillary lymph node metastases: screening with [F-18] 2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 1997;203(2):323-327.
15. Avril N, Dose J, Ziegler S, Jamicke F, Schwaiger M. Diagnosis of breast carcinoma and locoregional lymph nodes with positron emission tomography. Radiologe 1997;37(9):741-748.
16. Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, Chiesa C, De Sanctis V, Delledonne V, Salvadori B, Leutner M, Bombardieri E. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39(1):4-8.
17. Smith IC, Ogston KN, Withford P, Smith FW, Sharp P, Norton M, Miller ID, Ah-See AK, Heys SD, Jibril JA, Eremin O. Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg 1998; 228(2):220-227.
18. Lam WW, Yang WT, Chan YL, Stewart IE, Metreweli C, King W. Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med 1996;23(5)498-503.
19. Tolmos J, Khalkhali I, Vargas H, Stuntz M, Cutrone J, Mishkin F, Diggles L, Venegas R, Klein S. Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography. Am Surg 1997;63(10):850-853.
20. Taillefer R, Robidoux A, Turpin S, Lambert R, Cantin J, Leveille J. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer. J Nucl Med 1998;39(3):459-464.
21. Chili A, Agresti R, Maffioli L, Tomasic G, Savelli G, Crippa F, Pilotti S, Greco M, Bombardieri E. Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography. Eur J Nucl Med 1997;24:192-196.
22. Mansi L, Rambaldi PF, Cuccurullo V, Pecori B, Quarantelli M, Fallanca F, Del Vecchio E. Diagnostic and prognostic role of 99mTc-Tetrofosmin in breast cancer. Q J Nucl Med 1997;41:239-250.
23. Akcay MN, Akin Y, Karabag B, Ozcan O, Oren D. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI. Clin Nucl Med 1997;22 (12):832-834.
24. Schillaci O, Scopinaro F, Danieli R, Ierardi M, Picardi V, Cannas P, Tiberio NS, Di Luzio E, Monteleone F, CentiColella A. Tc-99m MIBI (M) and Tc-99m Tetrofosmin (TF) imaging in presurgical staging of the axilla in breast cancer (BC). Eur J Nucl Med 1998; 25(8): 872.
25. Schillaci O, Scopinaro F, Danieli R, Tavolaro R, Cannas P, Picardi V, Colella AC. Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer. Anticancer Res 1997;17(3B):1607-1610.
26. Spanu A, Dettori G, Farris A, Bagella C, Porcu A, Nuvoli S, Solinas P, Cottu P, Solinas ME, Chiaramida P, Masia A, Madeddu G. Technetium-99m Tetrofosmin SPECT in primary breast cancer detection and axillary lymph node staging. J Nucl Med 1998;39:314.
27. Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC. A prognostic index in primary breast cancer. Br J Cancer 1982;45:361-366.
28. Nemoto T, Vana J, Bedwani R, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917.
29. Fisher B, Bauer M, Wickerham L, Redmond C, Fisher E. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983;52:1551-1557.
30. Wanet PM, Sand A, Abramovici J. Physical and clinical evaluation of high-resolution thyroid pinhole tomography. J Nucl Med 1996;37(12):2017-2020.
31. Bahk YW, Chung SK, Park YH, Kim SH, Lee HK. Pinhole SPECT imaging in normal and morbid ankles. J Nucl Med 1998;39(1):130-139.
32. Manglos SH, Jaszezak RJ, Greer KL. Cone beam SPECT reconstruction with camera tilt. Phys Med Biol 1989;34(5):625-631.
33. Strand S-E, Ivanovic M, Erlandsson K, Franceschi D, Button T, Sjogren K, Weber DA. Small animals imaging with pinhole single-photon emission computed tomography. Cancer 1994;73(suppl):981-984.
34. Weber DA, Ivanovic M, Franceschi D, Strand S-E, Erlandsson K, Franceschi M, Button T, Ljunggren K. Pinhole SPECT: an approach to in vivo high resolution SPECT imaging in small laboratory animals. J Nucl Med 1994;35:342-348.
35. Yukihiro M, Inoue T, Iwasaki T, Tomiyoshi K, Erlandsson K, Endo K. Myocardial infarction in rats: high-resolution single photon emission tomographic imaging with a pinhole collimator. Eur J Nucl Med 1996;23(8):896-900.
36. Krausz Y, WiIk M, Saliman F, Chisin R. Role of high-resolution pinhole tomography in the evaluation of thyroid abnormalities. Thyroid 1997;7(6):847-852.
37. Spanu A, Solinas ME, Chiaramida P, Falchi A, Bagella C, Solinas P, Masia A, Nuvoli S, Madeddu G. Tc-99m Tetrofosmin (T) Pinhole (P) SPECT in neck metastases from differentiated thyroid carcinoma. Eur J Nucl Med 1998;25(8): 934.
38. 99mTc-Q12 into human breast cancer cell lines. Eur J Nucl Med 1996;23:1361-1366.
39. 99mTc-Tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med 1996;23:932-939.
40. Basoglu T, Sahin M, Coskun C, Koparan A, Bernay I, Erkan L. 99mTc-Tetrofosmin uptake in malignant lung tumours. Eur J Nucl Med 1995;22:687-689.
41. Kosuda S, Yokoyama H, Katayama M, YokoKawa T, Kusano S, Yamamoto O. 99mTc-Tetrofosmin and 99mTc-sestamibi imaging of multiple metastases from differentiated thyroid carcinoma. Eur J Nucl Med 1995;22:1218-1220.
42. Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med 1997;38(3):348-352.
43. Soricelli A, Cuocolo A, Varrone A, Discepolo A, Tedeschi E, Mainenti PP, Grivet-Fojaja MR, Covelli EM, Postiglione A, Salvatore M. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging. J Nucl Med 1998;39(5):802-806.
44. Spanu A, Farris A, Solinas P, Nuvoli S, Bagella C, Masia A, Solinas ME, Falchi A, Madeddu G. Tc-99m Tetrofosmin (T) scan in monitoring malignant melanoma patients.Preliminary results. Eur J Nucl Med 1998;25 (8):1058.
45. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-Tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996;37:1551-1556.
46. Spanu A, Dettori G, Meloni G, Chiaramida P, Bagella C, Porcu A, Solinas ME, Cottu P, Falchi A, Solinas P, Madeddu G. Tc-99m Tetrofosmin (T) scan in the diagnosis and staging of primary breast cancer: role of SPEC T. Eur J Nucl Med 1998;25(8):1041.